Early Arrival in Chestnut Hill
Olivers Murnieks, the Buffalo Sabres’ 2026 fourth‑round selection, announced that he will forgo a final year in the Quebec Major Junior Hockey League and begin his collegiate career with Boston College this fall.
The 18‑year‑old forward, who turned 18 on July 31, 2026, signed a letter of intent that places him on the Eagles’ roster for the upcoming 2026‑27 campaign, a move that surprised many given the typical progression from the QMJHL to the NCAA.
Murnieks spent the previous season with the Saint John Sea Dogs, recording 20 points in 31 games, and his performance earned him a spot on Latvia’s U18 and U20 squads, where he contributed 10 points in 12 appearances and logged five games with the senior national team at the 2026 IIHF World Championship without a point.
A New Chapter at Boston College
Coaches at Boston College view the early arrival as an opportunity to accelerate his development, projecting that he will need two to three seasons to refine his offensive consistency, improve shot quality and adapt to the higher tempo of elite prospects.
His first on‑ice test will be an exhibition match against the USA Hockey National Team Development Program on October 3, followed by the regular‑season opener on October 9 against Alaska, a schedule that will give him a quick gauge of collegiate competition.
Analysts note that while his skating burst and defensive reads are still works in progress, the prospect’s size and hockey sense suggest he could evolve into a reliable center if his offensive output climbs above current projections.
HockeyStats currently assigns Murnieks a 4 percent chance of becoming a full‑time NHL player based on a 200‑game threshold, a figure that reflects the competitive nature of the Sabres’ forward depth chart.
Nevertheless, the organization remains optimistic that the structured environment at Boston College, combined with exposure to top‑tier coaching, will provide the necessary framework for Murnieks to transition from a promising junior to an NHL‑ready center.